АФФЕКТИВНЫЕ И КОГНИТИВНЫЕ СИМПТОМЫ У ПЕРЕНЕСШИХ COVID-19 ПАЦИЕНТОВ: ОРГАНИЗАЦИОННЫЕ ВЫВОДЫ ОБ ОКАЗАНИИ ПСИХИАТРИЧЕСКОЙ ПОМОЩИ В ПЕРИОДЫ ПАНДЕМИИ И ПО ЕЁ ОКОНЧАНИИ

Библиографические ссылки:

Afshar-Oromieh A., Prosch H., Schaefer-Prokop C., Bohn K.P., Alberts I., Mingels C. et al. A comprehensive review of imaging findings in COVID-19 - status in early 2021. European Journal of Nuclear Medicine and Molecular Imaging. 2021; 48(8): 2500–24.

Mohamed Khosroshahi L., Rokni M., Mokhtari T., Noorbakhsh F. Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an Overview. International Immunopharmacology. 2021; 93: 107364.

Fountoulakis K., Karakatsoulis G., Abraham S., Adorjan K., Ahmed H., Alarcón R. et al. Results of the COVID-19 mental health international for the general population (COMET-G) study. European Neuropsychopharmacology. 2022; 54: 21–40.

Prati G., Mancini A. The psychological impact of COVID-19 pandemic lockdowns: A review and meta-analysis of longitudinal studies and natural experiments. Psychological Medicine. 2021; 51(2): 201-211. doi:10.1017/S0033291721000015

Lee Y., Lui LMW., Chen-Li D., Liao Y., Mansur R.B., Brietzke E. et al. Government response moderates the mental health impact of COVID-19: A systematic review and meta-analysis of depression outcomes across countries. J Affect Disord. 2021; 290: 364-377. doi: 10.1016/j.jad.2021.04.050.

Sorokin M., Kasyanov E., Rukavishnikov G., Makarevich O., Neznanov N., Lutova N. et al. Behavioral and Emotional Reactions of the Russian Population to the Beginning of the COVID-19 Pandemic: An On-Line Survey Results. Psychiatr Danub. 2021; 33(3): 386-392. doi: 10.24869/psyd.2021.386

Васильева А., Караваева Т., Радионов Д., Яковлев А. Исследование взаимосвязи социально-демографических характеристик и индивидуального опыта пандемии COVID-19 с отношением к вакцинации для определения мишеней психосоциальных интервенций. Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева. 2021; 55(2): 27-36. [Vasilyeva A., Karavaeva T., Radionov D., Yakovlev A. Study of the relationship between socio-demographic characteristics and individual experiences of the COVID-19 pandemic and attitudes toward vaccination to determine the targets of psychosocial interventions. V.M. Bekhterev Review of Psychiatry and Medical Psychology. 2021; 55(2): 27-36. (In Russ.)] doi: 10.31363/2313-7053-2021-55-2-27-36

Сорокин M., Лутова Н., Мазо Г., Незнанов Н., Касьянов Е., Рукавишников Г. и др. Структура тревожных переживаний и стресс как факторы готовности к вакцинации против коронавирусной инфекции. Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева. 2021; 55(2): 52-61. [Sorokin M., Lutova N., Mazo G., Neznanov N., Kasyanov E., Rukavishnikov G. et al. Structure of anxiety experiences and stress as factors of readiness for vaccination against coronavirus infection. The V.M. Bekhterev Review of Psychiatry and Medical Psychology. 2021; 55(2): 52-61. (In Russ.)] doi: 10.31363/2313-7053-2021-55-2-52-61

Spalletta G., Porcari D.E., Banaj N., Ciullo V., Palmer K. Effects of COVID-19 Infection Control Measures on Appointment Cancelation in an Italian Outpatient Memory Clinic. Frontiers in Psychiatry. 2020; 11: 1335

Chumakov E., Azarova L., Limankin O. Telemedicine in psychiatric care in the community and its satisfaction by outpatients during the COVID-19 outbreak in St. Petersburg, Russia. Vestnik of Saint Petersburg University. Medicine. 2021; 16(2): 106-115. doi: 10.21638/spbu11.2021.204

Alkasaby M., Philip S., Agrawal A., Jakhar J., Ojeahere M., Ori D. et al. Early career psychiatrists advocate reorientation not redeployment for COVID-19 care. International Journal of Social Psychiatry. 2021; doi: 10.1177/00207640211057734

Mosolova E., Sosin D. Stress, trevoga, depressiya i professional'noe vygoranie u meditsinskikh rabotnikov vo vremya dvukh voln pandemii COVID-19 v Rossii [Stress, anxiety, depression and burnout in healthcare workers during the first two outbreaks of COVID-19 in Russia]. Zh Nevrol Psikhiatr Im S S Korsakova. 2022; 122(6): 128-133. In Russian. doi: 10.17116/jnevro2022122061128.

Сорокин М., Касьянов Е., Рукавишников Г. Mакаревич О., Незнанов Н., Семенова Н. и др. Влияние пандемии COVID-19 на психическое здоровье медицинских работников в России. Медицинская этика. 2020; 8(2): 27-34. [Sorokin M., Kasyanov E., Rukavishnikov G. Makarevich O., Neznanov N., Semenova N. et al. Impact of the COVID-19 pandemic on the mental health of medical workers in Russia. Medical Ethics. 2020; 8(2): 27-34. (In Russ.)]

Mogharab V., Ostovar M., Ruszkowski J. et al. Global burden of the COVID-19 associated patient-related delay in emergency healthcare: a panel of systematic review and meta-analyses. Global Health. 2022; 18: 58. doi: 10.1186/s12992-022-00836-2

Шереметьева И., Строганов А., Кулешова Е., Стреминский С. Обращаемость за медицинской помощью пациентов с расстройствами шизофренического спектра в условиях пандемии COVID-19. Сибирский вестник психиатрии и наркологии. 2022; 4(113): 22-28. [Sheremetieva I., Stroganov A., Kuleshova E., Streminsky S. The appeal for medical care of patients with schizophrenic spectrum disorders in conditions of the COVID-19 pandemic. Siberian Bulletin of Psychiatry and Narcology. 2022; 4(113): 22-28. (In Russ.)]

Sorokin M., Palchikova E., Kibitov A., Kasyanov E., Khobeysh M., Zubova E. Mental State of Inpatients With COVID-19: A Computational Psychiatry Approach. Front Psychiatry. 2022; 13: 801135. doi: 10.3389/fpsyt.2022.801135

Аленина О., Диденко А., Бохан Н. Характеристика спектра психопатологических проявлений у пациентов, перенесших инфекцию COVID-19. Бюллетень медицинской науки. 2021; 1(21): 39-44. [Alenina O., Didenko A., Bohan N. Characteristics of the spectrum of psychopathological manifestations in patients who underwent COVID-19 infection. Bulletin of Medical Science. 2021; 1(21): 39-44. (In Russ.)]

Andreotti F., Gervasoni C., Di Pasquale G., Maggioni A.P. Methodological education in response to the quality of COVID-19 publications. Pharmacol Res. 2021; 164: 105381. doi: 10.1016/j.phrs.2020.105381

Keyes B., McCombe G., Broughan J., Frawley T., Guerandel A., Gulati G., et al. Enhancing GP care of mental health disorders post-COVID-19: A scoping review of interventions and outcomes. Irish Journal of Psychological Medicine. 2022; 1-17. doi: 10.1017/ipm.2022.17

Varatharaj A., Thomas N., Ellul M.A., Davies N.W., Pollak T.A., Tenorio E.L. et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: A UK-wide surveillance study. The Lancet Psychiatry. 2020; 7(10): 875–82.

Rogers J., David A. A longer look at COVID-19 and neuropsychiatric outcomes. The Lancet Psychiatry. 2021; 8(5): 351–2.

Hampshire A., Trender W., Chamberlain S.R., Jolly A.E., Grant J.E., Patrick F. et al. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. 2021; 39: 101044.

Diez‐Quevedo C., Iglesias‐González M., Giralt‐López M., Rangil T., Sanagustin D., Moreira M. et al. Mental disorders, psychopharmacological treatments, and mortality in 2150 Covid‐19 Spanish inpatients. Acta Psychiatrica Scandinavica. 2021; 143(6):526–34.

Castilla J., Guevara M., Miqueleiz A., Baigorria F., Ibero-Esparza C., Navascués A. et al. Risk factors of infection, hospitalization and death from SARS-COV-2: A population-based Cohort Study. Journal of Clinical Medicine. 2021; 10(12): 2608.

Shah W., Hillman T., Playford E., Hishmeh L. Managing the long term effects of COVID-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021; n136.

Ceban F., Ling S., Lui L., Lee Y., Gill H., Teopiz K. et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain, Behavior, and Immunity. 2022; 101: 93-135.

Aiyegbusi O., Hughes S., Turner G., Rivera S., McMullan C., Chandan J. et al. Symptoms, complications and management of long COVID: a review. Journal of the Royal Society of Medicine. 2021; 114(9): 428–442. doi: 10.1177/01410768211032850

Hawke L., Nguyen A., Ski C., Thompson D., Ma C., Castle D. Interventions for mental health, cognition, and psychological wellbeing in long COVID: A systematic review of registered trials. Psychological Medicine. 2022; 1-44. doi: 10.1017/S0033291722002203

Renaud-Charest O., Lui LMW., Eskander S., Ceban F., Ho R., Di Vincenzo J.D. et al. Onset and frequency of depression in post-COVID-19 syndrome: A systematic review. J Psychiatr Res. 2021; 144: 129-137. doi: 10.1016/j.jpsychires.2021.09.054.

Vanderlind W., Rabinovitz B., Miao I., Oberlin L., Bueno-Castellano C., Fridman C. et al. A systematic review of neuropsychological and psychiatric sequalae of COVID-19: implications for treatment. Current Opinion in Psychiatry. 2021; 34(4): 420-433.

Liu C., Pan W., Li L., Li B., Ren Y., Ma X. Prevalence of depression, anxiety, and insomnia symptoms among patients with COVID-19: A meta-analysis of quality effects model. J Psychosom Res. 2021; 147: 110516. doi: 10.1016/j.jpsychores.2021.110516

Zeng N., Zhao Y., Yan W. et al. A systematic review and meta-analysis of long-term physical and mental sequelae of COVID-19 pandemic: call for research priority and action. Mol Psychiatry. 2022. doi: 10.1038/s41380-022-01614-7

Tavares-Júnior JWL., de Souza ACC., Borges JWP., Oliveira D.N., Siqueira-Neto J.I., Sobreira-Neto M.A. et al. COVID-19 associated cognitive impairment: A systematic review. Cortex. 2022; 152: 77-97. doi: 10.1016/j.cortex.2022.04.006

Alkodaymi M., Omrani O., Fawzy N., Shaar B., Almamlouk R., Riaz M. et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clinical Microbiology and Infection. 2022; 28(5): 657-666.

Lyra E., Silva N.M., Barros-Aragão FGQ., De Felice F.G., Ferreira S.T. Inflammation at the crossroads of COVID-19, cognitive deficits and depression. Neuropharmacology. 2022; 209: 109023. doi: 10.1016/j.neuropharm.2022.109023.

Clift A.K., Ranger T.A., Patone M. et al. Neuropsychiatric Ramifications of Severe COVID-19 and Other Severe Acute Respiratory Infections. JAMA Psychiatry. 2022; 79(7): 690–698. doi:10.1001/jamapsychiatry.2022.1067

Almeria M., Cejudo J.C., Sotoca J., Deus J., Krupinski J. Cognitive profile following COVID-19 infection: Clinical predictors leading to neuropsychological impairment. Brain Behav Immun Health. 2020 Dec; 9: 100163. doi: 10.1016/j.bbih.2020.100163

Daly M., Sutin A.R., Robinson E. Depression reported by US adults in 2017-2018 and March and April 2020. J Affect Disord. 2021; 278: 131-135. doi: 10.1016/j.jad.2020.09.065

Depression [Internet]. Who. int. 2022 [cited 8 August 2022]. Available from:https://www.who.int/news-room/fact-sheets/detail/depression

Mental disorders [Internet]. Who.int. 2022 [cited 8 August 2022]. Available from:https://www.who.int/news-room/fact-sheets/detail/mental-disorders

Depression and other common mental disorders. WHO; 2017.

Lim G.Y., Tam W.W., Lu Y., Ho C.S., Zhang M.W., Ho R.C. Prevalence of Depression in the Community from 30 Countries between 1994 and 2014. Sci Rep. 2018 12; 8(1): 2861. doi: 10.1038/s41598-018-21243-x

COVID-19 Map - Johns Hopkins Coronavirus Resource Center [Internet]. Johns Hopkins Coronavirus Resource Center. 2022 [cited 15 July 2022]. Available from:https://coronavirus.jhu.edu/map.html

Evans-Lacko S., Aguilar-Gaxiola S., Al-Hamzawi A., Alonso J., Benjet C., Bruffaerts R. et al. Socio-economic variations in the mental health treatment gap for people with anxiety, mood, and substance use disorders: results from the WHO World Mental Health (WMH) surveys. Psychol Med. 2018; 48(9):1560-1571. doi: 10.1017/S0033291717003336

Moitra M., Santomauro D., Collins P.Y., Vos T., Whiteford H., Saxena S., et al. The global gap in treatment coverage for major depressive disorder in 84 countries from 2000–2019: A systematic review and Bayesian meta-regression analysis. PLoS Med. 2022; 19(2): e1003901. doi: 10.1371/journal.pmed.1003901

Sinyor M., Rezmovitz J., Zaretsky A. Screen all for depression. BMJ. 2016; 352: i1617. doi: 10.1136/bmj.i1617

Roberto N., Portella M., Marquié M. et al. Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis. Sci Rep. 2021; 11: 6448. doi: 10.1038/s41598-021-83126-y

Taragano F.E., Allegri R.F., Heisecke S.L., Martelli M.I., Feldman M.L., Sánchez V. et al. Risk of Conversion to Dementia in a Mild Behavioral Impairment Group Compared to a Psychiatric Group and to a Mild Cognitive Impairment Group. J Alzheimers Dis. 2018; 62(1): 227-238. doi: 10.3233/JAD-170632

Thaipisuttikul P., Jaikla K., Satthong S., Wisajun P. Rate of conversion from mild cognitive impairment to dementia in a Thai hospital-based population: A retrospective cohort. Alzheimers Dement (NY). 2022; 8(1): e12272. doi: 10.1002/trc2.12272

Деменция [Internet]. Who. int. 2022 [cited 8 August 2022]. Available from:https://www.who.int/ru/news-room/fact-sheets/detail/dementia

Salzman T., Sarquis-Adamson Y., Son S., Montero-Odasso M., Fraser S. Associations of Multidomain Interventions With Improvements in Cognition in Mild Cognitive Impairment: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022; 5(5): e226744. doi: 10.1001/jamanetworkopen.2022.6744